Article
Immunologic effects in patients with psoriatic arthritis treated with cyclosporine A.
The Journal of rheumatology - 1 Dec 1992
Boiardi L, Salvarani C, Macchioni P, Casadei Maldini M, Mancini R, Beltrandi E, Rossi F, Lodi L, Portioli I
Abstract excerpt
Twelve patients with psoriatic arthritis (PsA) and very active articular disease resistant to conventional second line therapy entered into a 6-month open study of cyclosporine A (CsA) at a starting dosage of 3 mg/kg/day. Comparisons of phenotypic characteristics of lymphocytes and response to mitogens of peripheral blood mononuclear cells (PBMC) were made between these patients with PsA before CsA therapy, 7...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.